SCHEDULE 13GFiled Feb 23, 7:00 PM ET
Aardvark Therapeutics, Inc. SCHEDULE 13G
Decheng Capital Global Life Sciences Fund IV, L.P.Summary not available
This filing does not have a generated research summary. You can still open the original filing and its exhibits.